Prognostic value of pathological lymph node status and primary tumour regression grading following neoadjuvant chemotherapy - results from the MRC OE02 oesophageal cancer trial

Nasser Davarzani, Gordon G. A. Hutchins, Nicholas P. West, Lindsay C. Hewitt, Matthew Nankivell, David Cunningham, William H. Allum, Elizabeth Smyth, Nicola Valeri, Ruth E. Langley, Heike I. Grabsch*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1180-1188
Number of pages9
JournalHistopathology
Volume72
Issue number7
DOIs
Publication statusPublished - Jun 2018

Keywords

  • oesophageal carcinoma
  • neoadjuvant chemotherapy
  • tumour regression grade
  • PREOPERATIVE CHEMORADIOTHERAPY
  • CARCINOMA
  • THERAPY
  • SURVIVAL
  • RADIOCHEMOTHERAPY
  • ADENOCARCINOMAS
  • CHEMORADIATION
  • Prognosis
  • Esophageal Neoplasms/drug therapy
  • Humans
  • Middle Aged
  • Male
  • Lymphatic Metastasis/pathology
  • Neoplasm Grading
  • Lymph Nodes/pathology
  • Adult
  • Female
  • Neoadjuvant Therapy
  • Aged
  • Chemotherapy, Adjuvant

Cite this